English

This document describes the process of task analysis that is necessary in order to design and develop relevant, useful training materials.

This Global Alliance for TB Drug Development (TB Alliance) report contains portfolio updates, team information, and project summaries on their research for new TB drugs.

This slide set was developed as an accompaniment to the Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis (MMWR), a joint statement by the National Tuberculosis Controllers Association and CDC. The slide set provides an overview of the current recommendations for conducting contact investigations.

This fact sheet provides information on the BCG vaccine and its effects on TB skin tests. Contact information for Toronto TB clincs is also given.

This electronic resource provides an interface for entering patient data to create a drug-o-gram. It includes a user's guide with instructions and teaching points. To download the program, Windows 2000/XP and Microsoft Access are required.

This fact sheet explains who should and who should not get vaccinated against TB. It also explains how to interpret tuberculin skin test results in people who have received the vaccination and the treatment for LTBI in BCG-vaccinated persons.

This fact sheet provides information on tuberculin skin testing. It explains how to interpret tuberculin skin test (TST) results, including special considerations. 

This fact sheet details the three levels of TB infection control in health-care settings, considerations for selection of respirators, and implementing a respiratory protection program.

This fact sheet gives an overview of TB infection-control measures and explains how to determine the infectiousness of TB patients.

This fact sheet details the difference between Latent TB Infection (LTBI) and Active TB Disease. A general description of TB is also given.